MACOM Technology vs Tempus AI — how do they compare? MACOM Technology trades at $284.01 (market cap $20.99B), while Tempus AI trades at $61.18 (market cap $11.67B). The key difference: MACOM Technology is the larger of the two by market cap, and MACOM Technology is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| MTSI | TEM | |
|---|---|---|
Market Cap | $20.99B | $11.67B |
Sector | Technology | Broad Market / Factor |
52-Week High | $409.68 | $103.25 |
52-Week Low | $122.18 | $41.55 |
Enterprise Value | $20.70B | $12.30B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats despite negative profitability, with a P/S of 7.99 and P/B of 26.23. Recent catalysts include FDA clearance for an AI ECG product and a $9.5 million ARPA-H award for autonomous AI in cardiology (Business Wire, September 9, 2026).
Outlook remains positive given analyst consensus and growth in precision medicine, but risks include sustained losses, high valuation multiples, and cash burn. The consensus price target is $69.11, implying potential upside, though investors must weigh the company's unprofitability against its innovation pipeline and market position.
Trailing returns across standard periods
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →